Travel Vaccines Market

1
Travel Vaccines
Global Market Report 2024 Global Forecast 2024
2033 Market Size, Drivers, And Trends
Top Market Research Firm 2023! We are honored to
be listed as a top company at the forefront of
research, by the Business Management Review
2
Travel Vaccines Market Segment
The Business Research Company segments the travel
vaccines market report as
Hepatitis A, Diphtheria, Pertussis, And Tetanus
(DPT), Yellow Fever Typhoid Hepatitis B
Measles And Mumps Rabies Meningococcal Other
Diseases
ByByTeScohunrocelogy
Mono Vaccines, Combination Vaccines
By CBoymFopromsition
Online Booking, In-Person Booking
ByBAypBpoloickaitniogn
Domestic Travel, Outbound Travel
By App.lication
.
Domestic Travel, Outbound Travel
By Application
.
.
3
Market Statistics
The travel vaccines market size has grown
strongly in

• recent years. It will grow from 4.41 billion in
  2023 to 4.79 billion in 2024 at a compound
  annual growth rate (CAGR) of 8.7. The travel
  vaccines market size is expected to see strong
  growth in the next few years. It will grow to
  6.79 billion in 2028 at a compound annual
  growth rate (CAGR) of 9.1.

6.79 B
4.79 B
4.41 B
Click Here To Get A Sample Report
4
Key Market Drivers And Trends
Drivers The increase in travel and tourism is
expected to propel the growth of the travel
vaccine market going forward. Trends Product
innovation is a key trend gaining popularity in
the travel vaccine market. Region North
America was the largest region in the travel
vaccines market in 2023. Asia-Pacific is
expected to be the fastest-growing region in the
forecast period. The regions covered in the
travel vaccines market report are Asia-Pacific,
Western Europe, Eastern Europe, North America,
South America, Middle East, Africa.
5
Top Players In The Market
Major companies operating in the travel vaccines
market report are Pfizer Inc., Johnson and
Johnson, Merck Co. Inc., Novartis AG, Sanofi
SA, AstraZeneca PLC., GlaxoSmithKline plc,
Moderna Inc., BioNTech Europe GmbH, Biological
E. Limited, Bausch Health Companies Inc., Takeda
Pharmaceutical Company Limited, Novavax Inc.,
Emergent BioSolutions UK, Serum Institute of
India Pvt. Ltd., Dynavax Technologies, Bavarian
Nordic A/S, Valneva SE, Panacea Biotec,
Vabiotech, Inovio Pharmaceuticals, Bharat Biotech
International Limited, Altimmune Inc., Bio
Farma, Vaxart Inc.
Get More Information On The Market Report
6
7 Reasons Why TBRC Is The Solution You Need

1. Global Macroeconomic Impact Assess global
   economic factors' influence on market growth.
2. Market Size Ratios Explore market size, GDP
   proportions, and expenditure per capita.
3. Global Perspective Reports cover 60 geographies
   for a comprehensive global understanding.
4. Localized Strategies Create region-specific
   strategies aligning with market nuances.
5. Investment Insights Identify growth segments
   through forecast data and market insights.
6. Competitor Benchmarking Compare performance
   against key competitors.
7. Presentation Support Reports offer reliable data
   for internal and external presentations.

7
Americas The Business Research Company, 1295 N
Providence Rd, Oxygen, PA 19063, USA ? 1
3156230293
Get In Touch How ever you want to grow and
expand, The Business Research Company can help
as we provide research consulting solutions for
businesses, government agencies consultancies,
and market research companies.
Europe The Business Research Company 47
Anchorage Point, 42 Cuba Street, Canary Wharf,
London, England, E14 8NE
? 44 207 1930 708
Asia The Business Research Company, 1st Floor,
Anshu Colors Building, Road Number 1, Park View
Enclave, Jubilee Hills, Hyderabad (India), 500033
info_at_tbrc.info
? 91 8897263534
_at_The Business Research Company. All rights
reserved.
rch Company. All Rights Reserved.
The Business Resea
8
Your Growth Insights Partner
The Business Research Company. All Rights
Reserved.